EC
AARD

EcoR1 Capital’s Aardvark Therapeutics AARD Stock Holding History

EcoR1 Capital’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Buy
+396,194
New +$1.85M 0.11% 29

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.23B AUM 74.49% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital's AARD Position: Q2 2026 in Review

EcoR1 Capital opened a new position in Aardvark Therapeutics (AARD) in Q2 2026: 396,194 shares worth $2.28M. The stake represents 0.11% of the portfolio and ranks #29 among its holdings.

71 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • EcoR1 Capital held 396,194 shares of Aardvark Therapeutics worth $2.28M as of Q2 2026.
  • Aardvark Therapeutics was a new EcoR1 Capital position in Q2 2026.
  • Aardvark Therapeutics made up 0.11% of EcoR1 Capital's portfolio in Q2 2026, its #29 holding.
  • 71 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on EcoR1 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.